These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 8423847)

  • 1. Mimicking ligands.
    Heng JE; Dreyer EB
    Nature; 1993 Jan; 361(6409):211; author reply 212. PubMed ID: 8423847
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors.
    Davis SJ; Schockmel GA; Somoza C; Buck DW; Healey DG; Rieber EP; Reiter C; Williams AF
    Nature; 1992 Jul; 358(6381):76-9. PubMed ID: 1614536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding.
    el Ahmar W; Poumbourios P; McPhee DA; Kemp BE
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):855-8. PubMed ID: 1720631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV: conformational camouflage.
    Jardetzky T
    Nature; 2002 Dec; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract]   [Full Text] [Related]  

  • 5. In search of a better HIV vaccine - the heat is on.
    Phimister EG
    N Engl J Med; 2003 Feb; 348(7):643-4. PubMed ID: 12584375
    [No Abstract]   [Full Text] [Related]  

  • 6. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
    Wu L; Gerard NP; Wyatt R; Choe H; Parolin C; Ruffing N; Borsetti A; Cardoso AA; Desjardin E; Newman W; Gerard C; Sodroski J
    Nature; 1996 Nov; 384(6605):179-83. PubMed ID: 8906795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes.
    Hasunuma T; Tsubota H; Watanabe M; Chen ZW; Lord CI; Burkly LC; Daley JF; Letvin NL
    J Immunol; 1992 Mar; 148(6):1841-6. PubMed ID: 1371792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1.
    Kirsh R; Hart TK; Ellens H; Miller J; Petteway SA; Lambert DM; Leary J; Bugelski PJ
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1209-12. PubMed ID: 2252640
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site.
    McKeating JA; Moore JP; Ferguson M; Marsden HS; Graham S; Almond JW; Evans DJ; Weiss RA
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):451-9. PubMed ID: 1376134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera.
    Ghetie V; Wheeler T; Scott D; Uhr JW; Vitetta ES
    AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1945-8. PubMed ID: 1489581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.
    Kolchinsky P; Kiprilov E; Sodroski J
    J Virol; 2001 Mar; 75(5):2041-50. PubMed ID: 11160708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
    Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
    Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies.
    Golding H; Ouyang J; Zaitseva M; Broder CC; Dimitrov DS; Lapham C
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):149-59. PubMed ID: 10029247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.
    Moore JP; Klasse PJ
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):443-50. PubMed ID: 1599754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
    Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
    J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
    Martín-García J; Cocklin S; Chaiken IM; González-Scarano F
    J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression.
    Chien PC; Cohen S; Kleeberger C; Giorgi J; Phair J; Zolla-Pazner S; Hioe CE
    J Infect Dis; 2002 Jul; 186(2):205-13. PubMed ID: 12134256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of HIV-1 gp120 to the nicotinic receptor.
    Bracci L; Lozzi L; Rustici M; Neri P
    FEBS Lett; 1992 Oct; 311(2):115-8. PubMed ID: 1397297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gp120-CD4 interface: structural, immunological and pathological considerations.
    Kieber-Emmons T; Jameson BA; Morrow WJ
    Biochim Biophys Acta; 1989 Dec; 989(3):281-300. PubMed ID: 2559777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.